Dr. Jason Ice, DO

NPI: 1467951863
Total Payments
$10,215
2024 Payments
$1,481
Companies
41
Transactions
668
Medicare Patients
2,580
Medicare Billing
$227,451

Payment Breakdown by Category

Food & Beverage$10,152 (99.4%)
Education$63.00 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,152 665 99.4%
Education $63.00 3 0.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,986 127 $0 (2024)
Novo Nordisk Inc $1,167 73 $0 (2024)
Biohaven Pharmaceutical Holding Company Ltd. $753.86 66 $0 (2022)
PFIZER INC. $656.51 47 $0 (2024)
Janssen Pharmaceuticals, Inc $566.83 34 $0 (2024)
Lilly USA, LLC $555.11 48 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $514.05 40 $0 (2024)
AstraZeneca Pharmaceuticals LP $448.66 23 $0 (2024)
GlaxoSmithKline, LLC. $409.73 30 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $365.47 26 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,481 90 ABBVIE INC. ($261.23)
2023 $2,857 190 ABBVIE INC. ($603.22)
2022 $3,821 273 Biohaven Pharmaceutical Holding Company Ltd. ($753.86)
2021 $1,892 111 AbbVie Inc. ($452.25)
2020 $19.58 1 Merck Sharp & Dohme Corporation ($19.58)
2018 $144.09 3 EKOS Corporation ($117.72)

All Payment Transactions

668 individual payment records from CMS Open Payments — Page 1 of 27

Date Company Product Nature Form Amount Type
12/20/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $15.09 General
12/17/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $18.97 General
Category: Diabetes Care
12/16/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $15.15 General
Category: DIABETES
12/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $12.90 General
Category: RESPIRATORY
12/12/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $22.97 General
Category: Cardio-renal
12/12/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $15.82 General
Category: Diabetes
12/02/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Gastroenterology
11/27/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $7.70 General
Category: Diabetes
11/25/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $18.35 General
Category: VACCINES
11/21/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE Food and Beverage In-kind items and services $17.91 General
Category: VACCINE
11/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.17 General
Category: RESPIRATORY
11/19/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $16.95 General
Category: RESPIRATORY
11/18/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.98 General
Category: Diabetes
11/14/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.22 General
Category: Cardiovascular
11/06/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.17 General
Category: RESPIRATORY
11/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.50 General
Category: Respiratory
10/30/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $10.20 General
10/27/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $11.04 General
Category: VACCINES
10/18/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $19.32 General
Category: Diabetes
10/15/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $9.30 General
Category: NEUROSCIENCE
10/08/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $15.51 General
Category: RESPIRATORY
10/08/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $12.00 General
Category: RESPIRATORY
10/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $20.27 General
Category: NEUROSCIENCE
10/02/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $21.63 General
Category: Biological
09/30/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $19.33 General
Category: DIABETES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 1,275 1,844 $277,874 $122,387
2022 24 976 1,404 $197,629 $77,471
2021 10 329 465 $55,350 $27,594
Total Patients
2,580
Total Services
3,713
Medicare Billing
$227,451
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 142 454 $52,210 $27,499 52.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 143 175 $39,025 $16,683 42.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 174 174 $35,322 $15,912 45.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 234 340 $42,556 $14,093 33.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 121 177 $31,070 $12,129 39.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 139 168 $21,000 $10,109 48.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 56 60 $19,380 $7,745 40.0%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 11 12 $7,980 $3,380 42.4%
90662 Influenza vaccine split virus, preservative free Office 2023 42 42 $2,814 $2,758 98.0%
99235 Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes Facility 2023 24 25 $7,125 $2,578 36.2%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 15 15 $3,526 $2,402 68.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 20 22 $3,520 $2,049 58.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 12 13 $3,185 $1,401 44.0%
G0008 Administration of influenza virus vaccine Office 2023 44 44 $1,936 $1,292 66.7%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 19 19 $3,021 $1,239 41.0%
83036 Hemoglobin a1c level Office 2023 44 58 $2,320 $552.16 23.8%
G0009 Administration of pneumococcal vaccine Office 2023 11 11 $484.00 $322.96 66.7%
96372 Injection of drug or substance under skin or into muscle Office 2023 12 23 $1,196 $215.80 18.0%
81003 Automated urinalysis test Office 2023 12 12 $204.00 $26.40 12.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 97 107 $23,861 $10,467 43.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 143 224 $28,369 $8,592 30.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 129 151 $18,875 $8,204 43.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 53 149 $17,135 $8,169 47.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 100 100 $20,300 $7,828 38.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 75 116 $19,386 $6,669 34.4%

About Dr. Jason Ice, DO

Dr. Jason Ice, DO is a Internal Medicine healthcare provider based in Parma, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1467951863.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Ice, DO has received a total of $10,215 in payments from pharmaceutical and medical device companies, with $1,481 received in 2024. These payments were reported across 668 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($10,152).

As a Medicare-enrolled provider, Ice has provided services to 2,580 Medicare beneficiaries, totaling 3,713 services with total Medicare billing of $227,451. Data is available for 3 years (2021–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Parma, OH
  • Active Since 02/12/2018
  • Last Updated 11/24/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1467951863

Products in Payments

  • NURTEC ODT (Drug) $1,077
  • UBRELVY (Drug) $708.42
  • XIFAXAN (Drug) $514.05
  • Ozempic (Drug) $427.87
  • XARELTO (Drug) $414.22
  • Rybelsus (Drug) $368.85
  • TRELEGY ELLIPTA (Drug) $362.99
  • JARDIANCE (Drug) $343.90
  • VRAYLAR (Drug) $332.22
  • QULIPTA (Drug) $324.68
  • AirDuo Digihaler (Drug) $256.78
  • LINZESS (Drug) $251.44
  • Kerendia (Drug) $239.05
  • RYBELSUS (Drug) $238.76
  • ELIQUIS (Drug) $211.22
  • FARXIGA (Drug) $200.36
  • MOUNJARO (Drug) $197.92
  • FREESTYLE LIBRE 3 (Device) $192.70
  • CREON (Drug) $170.96
  • Auvelity (Drug) $156.13

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Parma